Dec 5 (Reuters) - Health Canada:
* INFORMATION UPDATE - HEALTH CANADA EVALUATING NDMA IN METFORMIN DRUGS
* HEALTH CANADA - AWARE SOME METFORMIN PRODUCTS AVAILABLE OUTSIDE CANADA HAVE BEEN FOUND TO CONTAIN NITROSAMINE IMPURITY, NDMA ABOVE ACCEPTABLE LIMIT
* HEALTH CANADA SAYS IS NOT AWARE OF ANY AFFECTED PRODUCTS IN CANADA AT THIS TIME
* HEALTH CANADA- WORKING TO ADDRESS ISSUE OF NDMA AND OTHER NITROSAMINE IMPURITIES FOUND IN CERTAIN MEDICATIONS SINCE SUMMER OF 2018